JP Morgan Chase’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
JP Morgan Chase's ORIC Position: Q3 2026 in Review
JP Morgan Chase reduced its Oric Pharmaceuticals (ORIC) stake by 83% in Q3 2026, selling an estimated $3.19M and leaving 51,674 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #5005.
JP Morgan Chase first reported a position in ORIC in Q2 2020 and has held it in 26 quarters since. The position peaked at $14.7M in Q3 2025. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- JP Morgan Chase held 51,674 shares of Oric Pharmaceuticals worth $691K as of Q3 2026.
- JP Morgan Chase sold 256,594 Oric Pharmaceuticals shares in Q3 2026, an estimated $3.19M.
- Oric Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #5005 holding.
- JP Morgan Chase first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 26 quarters since.
- JP Morgan Chase's Oric Pharmaceuticals position peaked at $14.7M in Q3 2025.
- 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.